WUXAY vs. TEVA
Compare and contrast key facts about WuXi AppTec Co. Ltd (WUXAY) and Teva Pharmaceutical Industries Limited (TEVA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WUXAY or TEVA.
Correlation
The correlation between WUXAY and TEVA is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
WUXAY vs. TEVA - Performance Comparison
Loading data...
Key characteristics
WUXAY:
0.96
TEVA:
0.22
WUXAY:
0.58
TEVA:
0.85
WUXAY:
1.10
TEVA:
1.11
WUXAY:
-0.26
TEVA:
0.17
WUXAY:
-0.69
TEVA:
0.82
WUXAY:
30.58%
TEVA:
17.26%
WUXAY:
101.03%
TEVA:
47.83%
WUXAY:
-82.64%
TEVA:
-90.80%
WUXAY:
-67.22%
TEVA:
-73.19%
Fundamentals
WUXAY:
$23.48B
TEVA:
$19.42B
WUXAY:
$0.54
TEVA:
-$1.15
WUXAY:
0.59
TEVA:
1.17
WUXAY:
2.54
TEVA:
3.22
WUXAY:
$40.84B
TEVA:
$16.61B
WUXAY:
$17.16B
TEVA:
$8.17B
WUXAY:
$14.10B
TEVA:
$725.00M
Returns By Period
In the year-to-date period, WUXAY achieves a 3.44% return, which is significantly higher than TEVA's -18.51% return.
WUXAY
3.44%
9.65%
-0.40%
67.91%
N/A
N/A
TEVA
-18.51%
33.43%
3.40%
10.52%
10.24%
-10.79%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WUXAY vs. TEVA — Risk-Adjusted Performance Rank
WUXAY
TEVA
WUXAY vs. TEVA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for WuXi AppTec Co. Ltd (WUXAY) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
WUXAY vs. TEVA - Dividend Comparison
WUXAY's dividend yield for the trailing twelve months is around 4.22%, while TEVA has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WUXAY WuXi AppTec Co. Ltd | 4.22% | 1.85% | 1.23% | 0.67% | 0.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.49% | 3.75% | 2.07% | 2.38% |
Drawdowns
WUXAY vs. TEVA - Drawdown Comparison
The maximum WUXAY drawdown since its inception was -82.64%, smaller than the maximum TEVA drawdown of -90.80%. Use the drawdown chart below to compare losses from any high point for WUXAY and TEVA. For additional features, visit the drawdowns tool.
Loading data...
Volatility
WUXAY vs. TEVA - Volatility Comparison
The current volatility for WuXi AppTec Co. Ltd (WUXAY) is 11.28%, while Teva Pharmaceutical Industries Limited (TEVA) has a volatility of 15.01%. This indicates that WUXAY experiences smaller price fluctuations and is considered to be less risky than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
WUXAY vs. TEVA - Financials Comparison
This section allows you to compare key financial metrics between WuXi AppTec Co. Ltd and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WUXAY vs. TEVA - Profitability Comparison
WUXAY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, WuXi AppTec Co. Ltd reported a gross profit of 4.08B and revenue of 9.65B. Therefore, the gross margin over that period was 42.3%.
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported a gross profit of 1.88B and revenue of 3.89B. Therefore, the gross margin over that period was 48.2%.
WUXAY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, WuXi AppTec Co. Ltd reported an operating income of 4.29B and revenue of 9.65B, resulting in an operating margin of 44.5%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported an operating income of 706.00M and revenue of 3.89B, resulting in an operating margin of 18.1%.
WUXAY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, WuXi AppTec Co. Ltd reported a net income of 3.67B and revenue of 9.65B, resulting in a net margin of 38.0%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported a net income of 214.00M and revenue of 3.89B, resulting in a net margin of 5.5%.